Fig. 3

Change in the glycemic control of the participants. HbA1c was evaluated according to the clinical practice guidelines of the Japan Diabetes Society and the Japan Geriatrics Society Joint Committee. The glycemic target was set according to the baseline parameters, health status, and concomitant drug use of each subject. Fisher’s exact test was used to compare data at baseline and 6 months. ** P < 0.01